Sindoori Sriram

Healthcare M&A counsel to Sonic Healthcare in its acquisition of Pathology Watch.

Healthcare M&A counsel to Sonic Healthcare in the sale of its California clinical laboratory business to Labcorp.

Represented Bristol-Myers Squibb in its $13.4 billion divestiture of Celgene's OTEZLA® program to Amgen, in relation to its $90 billion acquisition of Celgene.

Represented Danaher in its $750 million divestment of certain lines of businesses to Sartorius AG.

Represented Arya Sciences Acquisition Corp. II in its $1.3 billion combination with Cerevel Therapeutics, Inc.

Represented Franchise Equity Partners in its strategic partnership with Valvoline Inc. and acquisition of 38+ Valvoline stores in Texas.

Represented Franchise Equity Partners in its acquisition of Precision Garage Door's nationwide 100+ units franchise operations.

Represented Treasury Wine Estates in its $1 billion acquisition of Daou Vineyards.

Represented Delphi Technologies PLC in its $3.3 billion sale to BorgWarner Inc.

Represented Fortive Corporation in the combination of its Tektronix Video business, a global leader in video testing, with Telestream, a leading provider of digital media tools and workflow solutions.